New Alzheimer's drugs 5 to 10 years away, expert says

03/19/2009 | Google

Experimental drugs that stopped or stalled the progression of Alzheimer's disease in late-stage studies could be launched in five to 10 years, said Simon Lovestone of the Institute of Psychiatry at King's College London. As many as 11 Alzheimer's treatments are in Phase III trials, and about 80 more are in early-stage development.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA